Literature DB >> 19695003

Psychometric development of the individualized Retinopathy-Dependent Quality of Life Questionnaire (RetDQoL).

Leonie S Brose1, Clare Bradley.   

Abstract

OBJECTIVES: Psychometric development of the Retinopathy-Dependent Quality of Life (RetDQoL) questionnaire in a cross-sectional study of 207 German patients with diabetic retinopathy. Forty patients (19%) also had clinically significant macular edema.
METHODS: Principal component analyses identified factor structure, and Cronbach's alpha assessed internal consistencies. Construct validity was examined by testing the additional impact of macular edema and expected relationships of RetDQoL scores with visual impairment, stage of diabetic retinopathy, subscales of the SF-12, and scores of the Retinopathy Treatment Satisfaction Questionnaire (RetTSQ). Analyses were conducted using the RetDQoL's AWI score (average weighted impact of diabetic retinopathy on 26 life domains) and its two overview items (present QoL in general and retinopathy-specific QoL). Content validity was investigated using an open-ended question to identify any additional items needed.
RESULTS: A forced one-factor solution of the 26 specific weighted impact ratings showed all items except working life (applicable to 27%) to load>0.55, and Cronbach's alpha was 0.96, showing very high reliability. Greater impairment, worse diabetic retinopathy, and macular edema were associated with greater negative impact on scores. AWI correlated as expected more highly with retinopathy-specific QoL (r=0.71, P<0.01) than with present QoL (r=0.28, P<0.01). RetDQoL scores correlated moderately with SF-12 subscales (r=0.22-0.51, P<0.01) and RetTSQ scores (r=0.27-0.51, P<0.01). For six domains, >60% of patients reported no impact. No additional domains were needed.
CONCLUSIONS: The RetDQoL is valid and reliable for patients with diabetic retinopathy with or without macular edema. It may be shortened if findings are confirmed cross-culturally.

Entities:  

Mesh:

Year:  2009        PMID: 19695003     DOI: 10.1111/j.1524-4733.2009.00589.x

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  7 in total

1.  The impact of diabetic retinopathy on quality of life: qualitative findings from an item bank development project.

Authors:  Eva K Fenwick; Konrad Pesudovs; Jyoti Khadka; Mohamed Dirani; Gwyn Rees; Tien Y Wong; Ecosse L Lamoureux
Journal:  Qual Life Res       Date:  2012-12       Impact factor: 4.147

2.  Evaluation of item candidates for a diabetic retinopathy quality of life item bank.

Authors:  Eva K Fenwick; Konrad Pesudovs; Jyoti Khadka; Gwyn Rees; Tien Y Wong; Ecosse L Lamoureux
Journal:  Qual Life Res       Date:  2012-11-08       Impact factor: 4.147

3.  A randomized clinical trial comparing fixed vs pro-re-nata dosing of Ozurdex in refractory diabetic macular oedema (OZDRY study).

Authors:  J Ramu; Y Yang; G Menon; C Bailey; N Narendran; C Bunce; A Quartilho; A T Prevost; P Hykin; S Sivaprasad
Journal:  Eye (Lond)       Date:  2015-10-23       Impact factor: 3.775

4.  Health-related quality of life, visual function and treatment satisfaction following intravitreal dexamethasone implant for diabetic macular edema.

Authors:  Jayashree Ramu; Irini Chatziralli; Yit Yang; Geeta Menon; Clare Bailey; Michael Eckstein; Phil Hykin; Sobha Sivaprasad
Journal:  Patient Prefer Adherence       Date:  2017-03-17       Impact factor: 2.711

5.  To study the impact of diabetic retinopathy on quality of life in Indian diabetic patients.

Authors:  Jyoti Deswal; Subina Narang; Nitin Gupta; Jitender Jinagal; Meenakshi Sindhu
Journal:  Indian J Ophthalmol       Date:  2020-05       Impact factor: 1.848

6.  Clinical efficacy and mechanistic evaluation of aflibercept for proliferative diabetic retinopathy (acronym CLARITY): a multicentre phase IIb randomised active-controlled clinical trial.

Authors:  Sobha Sivaprasad; A Toby Prevost; James Bainbridge; Rhiannon Tudor Edwards; David Hopkins; Joanna Kelly; Phil Luthert; Caroline Murphy; Jayashree Ramu; Negin Sarafraz-Shekary; Joana Vasconcelos; Beverley White-Alao; Philip Hykin
Journal:  BMJ Open       Date:  2015-09-14       Impact factor: 2.692

7.  Disparities between Ophthalmologists and Patients in Estimating Quality of Life Associated with Diabetic Retinopathy.

Authors:  Xiaofeng Zhu; Qian Sun; Haidong Zou; Xun Xu; Xi Zhang
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.